{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T06:50:45Z","timestamp":1772088645412,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","award":["IR.MUI.RESEARCH.REC.1398.830"],"award-info":[{"award-number":["IR.MUI.RESEARCH.REC.1398.830"]}],"id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s10072-020-04905-5","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T17:03:58Z","timestamp":1605891838000},"page":"2891-2901","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Assessment of mental health, knowledge, and attitude of patients with multiple sclerosis and neuromyelitis optica spectrum disorder in response to 2019 novel coronavirus"],"prefix":"10.1007","volume":"42","author":[{"given":"Vahid","family":"Shaygannejad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Afshari-Safavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2638-3463","authenticated-orcid":false,"given":"Boshra","family":"Hatef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,20]]},"reference":[{"issue":"10223","key":"4905_CR1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497\u2013506","journal-title":"Lancet"},{"key":"4905_CR2","unstructured":"World Health Organization (2020) Coronavirus disease 2019 (COVID-19) situation report \u2212109. May 8, 2020. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports. Accessed 9 May 2020"},{"key":"4905_CR3","unstructured":"World Health Organization (2020) Coronavirus disease (COVID-2019) situation report \u2212108. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports. Accessed 7 May 2020"},{"key":"4905_CR4","doi-asserted-by":"publisher","first-page":"ofy174","DOI":"10.1093\/ofid\/ofy174","volume":"5","author":"DJ Epstein","year":"2018","unstructured":"Epstein DJ, Dunn J, Deresinski S (2018) Infectious complications of multiple sclerosis therapies: implications for screening, prophylaxis, and management. Open Forum Infect Dis: Oxford University Press US 5:ofy174","journal-title":"Open Forum Infect Dis"},{"key":"4905_CR5","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1111\/ajt.15869","volume":"20","author":"L Zhu","year":"2020","unstructured":"Zhu L, Xu X, Ma K, Yang J, Guan H, Chen S, Chen Z, Chen G (2020) Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression. Am J Transplant 20:1859\u20131863","journal-title":"Am J Transplant"},{"issue":"9","key":"4905_CR6","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1007\/s10072-020-04570-8","volume":"41","author":"M Ghajarzadeh","year":"2020","unstructured":"Ghajarzadeh M, Bonavita S (2020) Are patients with multiple sclerosis (MS) at higher risk of COVID-19 infection? Neurol Sci 41(9):2315\u20132316","journal-title":"Neurol Sci"},{"issue":"7","key":"4905_CR7","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s10072-020-04519-x","volume":"41","author":"G Dalla Costa","year":"2020","unstructured":"Dalla Costa G, Leocani L, Montalban X, Guerrero AI, S\u00f8rensen PS, Magyari M et al (2020) Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study. Neurol Sci 41(7):1647\u20131650","journal-title":"Neurol Sci"},{"issue":"9","key":"4905_CR8","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1001\/jamaneurol.2020.2581","volume":"77","author":"C Louapre","year":"2020","unstructured":"Louapre C, Collongues N, Stankoff B, Giannesini C, Papeix C, Bensa C, Deschamps R, Cr\u00e9ange A, Wahab A, Pelletier J, Heinzlef O, Labauge P, Guilloton L, Ahle G, Goudot M, Bigaut K, Laplaud DA, Vukusic S, Lubetzki C, de S\u00e8ze J, for the Covisep investigators (2020) Clinical characteristics and outcomes in patients with coronavirus disease 2019 and multiple sclerosis. JAMA Neurol 77(9):1079\u20131088","journal-title":"JAMA Neurol"},{"issue":"8","key":"4905_CR9","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1007\/s10072-020-04522-2","volume":"41","author":"J Devogelaere","year":"2020","unstructured":"Devogelaere J, D\u2019hooghe MB, Vanderhauwaert F, D\u2019haeseleer M (2020) Coronavirus disease 2019: favorable outcome in an immunosuppressed patient with multiple sclerosis. Neurol Sci 41(8):1981\u20131983","journal-title":"Neurol Sci"},{"issue":"3","key":"4905_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1468-1331.2007.02041.x","volume":"15","author":"A Beiske","year":"2008","unstructured":"Beiske A, Svensson E, Sandanger I, Czujko B, Pedersen E, Aarseth J et al (2008) Depression and anxiety amongst multiple sclerosis patients. Eur J Neurol 15(3):239\u2013245","journal-title":"Eur J Neurol"},{"issue":"7416","key":"4905_CR11","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1136\/bmj.327.7416.646","volume":"327","author":"D Buljevac","year":"2003","unstructured":"Buljevac D, Hop W, Reedeker W, Janssens A, Van der Meche F, Van Doorn P et al (2003) Self reported stressful life events and exacerbations in multiple sclerosis: prospective study. Bmj. 327(7416):646\u2013640","journal-title":"Bmj."},{"issue":"4","key":"4905_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1191\/1352458506ms1296oa","volume":"12","author":"R Brown","year":"2006","unstructured":"Brown R, Tennant C, Sharrock M, Hodgkinson S, Dunn S, Pollard J (2006) Relationship between stress and relapse in multiple sclerosis: part II. Direct and indirect relationships. Mult Scler J 12(4):465\u2013475","journal-title":"Mult Scler J"},{"issue":"6","key":"4905_CR13","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/j.1468-1331.2010.03252.x","volume":"18","author":"JB Chanson","year":"2011","unstructured":"Chanson JB, Z\u00e9phir H, Collongues N, Outteryck O, Blanc F, Fleury M, Vermersch P, de Seze J (2011) Evaluation of health-related quality of life, fatigue and depression in neuromyelitis optica. Eur J Neurol 18(6):836\u2013841","journal-title":"Eur J Neurol"},{"key":"4905_CR14","doi-asserted-by":"publisher","first-page":"102083","DOI":"10.1016\/j.ajp.2020.102083","volume":"51","author":"D Roy","year":"2020","unstructured":"Roy D, Tripathy S, Kar SK, Sharma N, Verma SK, Kaushal V (2020) Study of knowledge, attitude, anxiety & perceived mental healthcare need in Indian population during COVID-19 pandemic. Asian J Psychiatr 51:102083","journal-title":"Asian J Psychiatr"},{"key":"4905_CR15","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1002\/jmv.25914","volume":"92","author":"W Wu","year":"2020","unstructured":"Wu W, Zhang Y, Wang P, Zhang L, Wang G, Lei G, Xiao Q, Cao X, Bian Y, Xie S, Huang F, Luo N, Zhang J, Luo M (2020) Psychological stress of medical staffs during outbreak of COVID-19 and adjustment strategy. J Med Virol 92:1962\u20131970. https:\/\/doi.org\/10.1002\/jmv.25914","journal-title":"J Med Virol"},{"issue":"4","key":"4905_CR16","doi-asserted-by":"publisher","first-page":"283","DOI":"10.34172\/aim.2020.13","volume":"23","author":"N Moghadasi","year":"2020","unstructured":"Moghadasi N (2020) Evaluation of the level of anxiety among Iranian multiple sclerosis fellowships during the outbreak of COVID-19. Arch Iran Med 23(4):283","journal-title":"Arch Iran Med"},{"key":"4905_CR17","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1001\/jama.2020.5893","volume":"323","author":"T Shanafelt","year":"2020","unstructured":"Shanafelt T, Ripp J, Trockel M (2020) Understanding and addressing sources of anxiety among health care professionals during the COVID-19 pandemic. Jama. 323:2133\u20132134","journal-title":"Jama."},{"key":"4905_CR18","doi-asserted-by":"publisher","unstructured":"Orsini A, Corsi M, Santangelo A et al (2020) Challenges and management of neurological and psychiatric manifestations in SARS-CoV-2 (COVID-19) patients. Neurol Sci 41(9):2353\u20132366. https:\/\/doi.org\/10.1007\/s10072-020-04544-w","DOI":"10.1007\/s10072-020-04544-w"},{"key":"4905_CR19","doi-asserted-by":"publisher","unstructured":"Naser Moghadasi A (2020) One aspect of coronavirus disease (COVID-19) outbreak in Iran: high anxiety among MS patients. Mult Scler Relat Disord 41:102138. https:\/\/doi.org\/10.1016\/j.msard.2020.102138","DOI":"10.1016\/j.msard.2020.102138"},{"key":"4905_CR20","doi-asserted-by":"publisher","unstructured":"Srichan P, Apidechkul T, Tamornpark R, Yeemard F, Khunthason S, Kitchanapaiboon S, Wongnuch P, Wongphaet A, Upala P, (2020) Knowledge, attitude and preparedness to respond to the 2019 novel coronavirus (COVID-19) among the bordered population of northern Thailand in the early period of the outbreak: a cross-sectional study. Available at SSRN: https:\/\/ssrn.com\/abstract=3546046 or https:\/\/doi.org\/10.2139\/ssrn.3546046","DOI":"10.2139\/ssrn.3546046"},{"key":"4905_CR21","doi-asserted-by":"publisher","unstructured":"Zhang M, Zhou M, Tang F, Wang Y, Nie H, Zhang L, You G (2020) Knowledge, attitude, and practice regarding COVID-19 among healthcare workers in Henan, China. J Hosp Infect 105(2):183\u2013187. https:\/\/doi.org\/10.1016\/j.jhin.2020.04.012","DOI":"10.1016\/j.jhin.2020.04.012"},{"issue":"1","key":"4905_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4103\/jrms.JRMS_271_20","volume":"25","author":"SH Javanmard","year":"2020","unstructured":"Javanmard SH, Nasirian M, Ataei B, Vaseghi G, Vaezi A, Changiz T (2020) Isfahan COvid-19 REgistry (I-CORE): design and methodology. J Res Med Sci 25(1):32","journal-title":"J Res Med Sci"},{"key":"4905_CR23","doi-asserted-by":"publisher","unstructured":"Azami M, YektaKooshali MH, Shohani M, Khorshidi A, Mahmudi L (2019) Epidemiology of multiple sclerosis in Iran: a systematic review and meta-analysis. PLoS One 14(4):e0214738. https:\/\/doi.org\/10.1371\/journal.pone.0214738","DOI":"10.1371\/journal.pone.0214738"},{"key":"4905_CR24","doi-asserted-by":"publisher","first-page":"102472","DOI":"10.1016\/j.msard.2020.102472","volume":"46","author":"MA Sahraian","year":"2020","unstructured":"Sahraian MA, Azimi A, Navardi S, Ala S, Moghadasi AN (2020) Evaluation of the rate of COVID-19 infection, hospitalization and death among Iranian patients with multiple sclerosis. Mult Scler Relat Disord 46:102472","journal-title":"Mult Scler Relat Disord"},{"key":"4905_CR25","doi-asserted-by":"publisher","first-page":"102195","DOI":"10.1016\/j.msard.2020.102195","volume":"43","author":"F Safavi","year":"2020","unstructured":"Safavi F, Nourbakhsh B, Azimi AR (2020) B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran. Mult Scler Relat Disord 43:102195","journal-title":"Mult Scler Relat Disord"},{"key":"4905_CR26","doi-asserted-by":"publisher","first-page":"102276","DOI":"10.1016\/j.msard.2020.102276","volume":"45","author":"M Barzegar","year":"2020","unstructured":"Barzegar M, Mirmosayyeb O, Ghajarzadeh M, Nehzat N, Vaheb S, Shaygannejad V, Vosoughi R (2020) Characteristics of COVID-19 disease in multiple sclerosis patients. Mult Scler Relat Disord 45:102276","journal-title":"Mult Scler Relat Disord"},{"key":"4905_CR27","doi-asserted-by":"publisher","unstructured":"Sahraian MA, Azimi A, Navardi S, Rezaeimanesh N, Naser Moghadasi A (2020) Evaluation of COVID-19 infection in patients with neuromyelitis optica spectrum disorder (NMOSD): a report from Iran. Mult Scler Relat Disord 44:102245. https:\/\/doi.org\/10.1016\/j.msard.2020.102245","DOI":"10.1016\/j.msard.2020.102245"},{"key":"4905_CR28","doi-asserted-by":"publisher","first-page":"102669","DOI":"10.1016\/j.autrev.2020.102669","volume":"19","author":"O Mirmosayyeb","year":"2020","unstructured":"Mirmosayyeb O, Vaheb S, Barzegar M, Shaygannejad V, Bonavita S, Ghajarzadeh M (2020) Screening neuromyelitis optica patients for COVID-19 infection. Autoimmun Rev 19:102669","journal-title":"Autoimmun Rev"},{"issue":"1","key":"4905_CR29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/ana.1032","volume":"50","author":"WI McDonald","year":"2001","unstructured":"McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50(1):121\u2013127","journal-title":"Ann Neurol"},{"issue":"6","key":"4905_CR30","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/ana.20703","volume":"58","author":"CH Polman","year":"2005","unstructured":"Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald criteria\u201d. Ann Neurol 58(6):840\u2013846","journal-title":"Ann Neurol"},{"issue":"2","key":"4905_CR31","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292\u2013302","journal-title":"Ann Neurol"},{"issue":"2","key":"4905_CR32","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintor\u00e9 M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162\u2013173","journal-title":"Lancet Neurol"},{"issue":"10","key":"4905_CR33","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology. 66(10):1485\u20131489","journal-title":"Neurology."},{"issue":"2","key":"4905_CR34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG, International Panel for NMO Diagnosis (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 85(2):177\u2013189","journal-title":"Neurology."},{"issue":"8","key":"4905_CR35","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1007\/s10072-020-04543-x","volume":"41","author":"IC Parodi","year":"2020","unstructured":"Parodi IC, Poeta MG, Assini A, Schirinzi E, Del Sette P (2020) Impact of quarantine due to COVID infection on migraine: a survey in Genova, Italy. Neurol Sci 41(8):2025\u20132027","journal-title":"Neurol Sci"},{"issue":"11","key":"4905_CR36","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444","journal-title":"Neurology"},{"issue":"2","key":"4905_CR37","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1348\/014466505X29657","volume":"44","author":"JD Henry","year":"2005","unstructured":"Henry JD, Crawford JR (2005) The short-form version of the depression anxiety stress scales (DASS-21): construct validity and normative data in a large non-clinical sample. Br J Clin Psychol 44(2):227\u2013239","journal-title":"Br J Clin Psychol"},{"issue":"2","key":"4905_CR38","first-page":"82","volume":"2","author":"A Asghari","year":"2008","unstructured":"Asghari A, Saed F, Dibajnia P (2008) Psychometric properties of the depression anxiety stress scales-21 (DASS-21) in a non-clinical Iranian sample. Int J Psychol 2(2):82\u2013102","journal-title":"Int J Psychol"},{"issue":"3","key":"4905_CR39","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4103\/jrpp.JRPP_19_42","volume":"8","author":"H Abbasian","year":"2019","unstructured":"Abbasian H, Hajimolaali M, Yektadoost A, Zartab S (2019) Antibiotic utilization in Iran 2000\u20132016: pattern analysis and benchmarking with organization for economic co-operation and development countries. J Res Pharm Pract 8(3):162\u2013167","journal-title":"J Res Pharm Pract"},{"issue":"4","key":"4905_CR40","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.ajic.2016.11.026","volume":"45","author":"A Jamhour","year":"2017","unstructured":"Jamhour A, El-Kheir A, Salameh P, Hanna PA, Mansour H (2017) Antibiotic knowledge and self-medication practices in a developing country: a cross-sectional study. Am J Infect Control 45(4):384\u2013388","journal-title":"Am J Infect Control"},{"issue":"7\u20138","key":"4905_CR41","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1345\/aph.1Q051","volume":"45","author":"EF Enato","year":"2011","unstructured":"Enato EF, Sounyo AA, Einarson TR (2011) Medication utilization and illness management study in Nigeria. Ann Pharmacother 45(7\u20138):924\u2013930","journal-title":"Ann Pharmacother"},{"key":"4905_CR42","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.puhe.2018.11.018","volume":"168","author":"N Torres","year":"2019","unstructured":"Torres N, Chibi B, Middleton L, Solomon V, Mashamba-Thompson T (2019) Evidence of factors influencing self-medication with antibiotics in low and middle-income countries: a systematic scoping review. Public Health 168:92\u2013101","journal-title":"Public Health"},{"issue":"8","key":"4905_CR43","first-page":"FC06","volume":"11","author":"K Hosseinzadeh","year":"2017","unstructured":"Hosseinzadeh K, Azimian J (2017) Iranians\u2019 self-report knowledge and practice about arbitrary use of antibiotics. J Clin Diagn Res 11(8):FC06\u2013FC09","journal-title":"J Clin Diagn Res"},{"key":"4905_CR44","doi-asserted-by":"publisher","unstructured":"Borges do Nascimento IJ, Cacic N, Abdulazeem HM, von Groote TC, Jayarajah U, Weerasekara I, Esfahani MA, Civile VT, Marusic A, Jeroncic A, Carvas Junior N, Pericic TP, Zakarija-Grkovic I, Meirelles Guimar\u00e3es SM, Luigi Bragazzi N, Bjorklund M, Sofi-Mahmudi A, Altujjar M, Tian M, Arcani DMC, O\u2019Math\u00fana DP, Marcolino MS (2020) Novel coronavirus infection (COVID-19) in humans: a scoping review and meta-analysis. J Clin Med 9(4):941. https:\/\/doi.org\/10.3390\/jcm9040941","DOI":"10.3390\/jcm9040941"},{"key":"4905_CR45","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1001\/jama.2020.2783","volume":"323","author":"L Lan","year":"2020","unstructured":"Lan L, Xu D, Ye G, Xia C, Wang S, Li Y, Xu H (2020) Positive RT-PCR test results in patients recovered from COVID-19. Jama. 323:1502\u20131503","journal-title":"Jama."},{"issue":"4","key":"4905_CR46","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/j.1467-8330.2012.01021.x","volume":"45","author":"J Everts","year":"2013","unstructured":"Everts J (2013) Announcing swine flu and the interpretation of pandemic anxiety. Antipode. 45(4):809\u2013825","journal-title":"Antipode."},{"key":"4905_CR47","doi-asserted-by":"publisher","first-page":"102014","DOI":"10.1016\/j.ajp.2020.102014","volume":"50","author":"D Banerjee","year":"2020","unstructured":"Banerjee D (2020) The COVID-19 outbreak: crucial role the psychiatrists can play. Asian J Psychiatr 50:102014","journal-title":"Asian J Psychiatr"},{"key":"4905_CR48","unstructured":"National MS society (2020) What You need to know about coronavirus (COVID-19). https:\/\/www.nationalmssociety.org\/What-you-need-to-know-about-Coronavirus-(COVID-19). Accessed 15 Apr 2020"},{"key":"4905_CR49","unstructured":"United Kingdom MS society (2020) COVID-19 coronavirus and MS treatments. https:\/\/www.mssociety.org.uk\/about-ms\/treatments-and-therapies\/disease-modifying-therapies\/covid-19-coronavirus-and-ms. Accessed 15 Apr 2020"},{"key":"4905_CR50","unstructured":"Ireland MS society (2020) COVID-19 and MS. https:\/\/www.ms-society.ie\/covid-19-and-ms (accessed April 15, 2020)"},{"key":"4905_CR51","unstructured":"Australia MS society (2020) COVID-19 information for people with MS. https:\/\/www.ms.org.au\/coronavirus. Accessed 8 Apr 2020"},{"key":"4905_CR52","unstructured":"Iran MS society (2020) Everything MS Patients should know about COVID-19. http:\/\/www.iranms.ir\/fa. Accessed 22 Apr 2020"},{"issue":"3","key":"4905_CR53","first-page":"1","volume":"26","author":"BH Cohen","year":"2020","unstructured":"Cohen BH, Busis NA, Ciccarelli L (2020) Coding in the world of COVID-19: non\u2013face-to-face evaluation and management care. Continuum. 26(3):1\u201325","journal-title":"Continuum."},{"key":"4905_CR54","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/S0140-6736(20)30460-8","volume":"395","author":"SK Brooks","year":"2020","unstructured":"Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, Rubin GJ (2020) The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet 395:912\u2013920","journal-title":"Lancet"},{"key":"4905_CR55","unstructured":"Multiple sclerosis and related disorders (2020) Rethinking high-risk groups in COVID-19. Article in press. https:\/\/www.msard-journal.com\/article\/S2211-0348(20)30215-7\/fulltext. Accessed 23 Apr 2020"},{"key":"4905_CR56","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/lt.25756","volume":"26","author":"L D'Antiga","year":"2020","unstructured":"D'Antiga L (2020) Coronaviruses and immunosuppressed patients. The facts during the third epidemic. Liver Transpl 26:832\u2013834","journal-title":"Liver Transpl"},{"issue":"11","key":"4905_CR57","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1177\/1352458516681198","volume":"23","author":"JM Wijnands","year":"2017","unstructured":"Wijnands JM, Kingwell E, Zhu F, Zhao Y, Fisk JD, Evans C et al (2017) Infection-related health care utilization among people with and without multiple sclerosis. Mult Scler J 23(11):1506\u20131516","journal-title":"Mult Scler J"},{"key":"4905_CR58","doi-asserted-by":"crossref","unstructured":"Corallo F, Buono VL, Genovese R, Palmeri R, Di Cara M, Rifici C et al (2019) A complex relation between depression and multiple sclerosis: a descriptive review. Neurol Sci 40(8):1551\u20131558","DOI":"10.1007\/s10072-019-03889-1"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04905-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-020-04905-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04905-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T08:12:55Z","timestamp":1625645575000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-020-04905-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,20]]},"references-count":58,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["4905"],"URL":"https:\/\/doi.org\/10.1007\/s10072-020-04905-5","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,20]]},"assertion":[{"value":"31 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved in ethical board of Isfahan University of medical sciences.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written Informed consent was obtained from all of the participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}